Mesothelioma Cancer Resources Blog
-
Researchers Report “Exciting” Results of PARP Inhibitors for Treating Mesothelioma and Other Cancers
Two years ago researchers reported that PARP inhibitors could be the key to defeating mesothelioma resistance to cisplatin, a common chemotherapy agent. Now, in a recent study, researchers have found this new class of drugs “shows early promise” for mesothelioma and many other cancer patients. According to an April 21 press release from American Association …
Label: Featured Story
Posted on Monday, May 18, 2015